Showing results (31-40 of 219) with videos related to
Sort By:
Pageof 22
Molecular Immunology|November 25, 2015
Complement system activation in ANCA vasculitis: A translational success story?Cees G M Kallenberg, Peter HeeringaCurrent Opinion in Rheumatology|November 18, 2011
Pathogenesis of ANCA-associated vasculitis: recent insights from animal modelsMirjan M van Timmeren, Peter HeeringaKidney International|December 29, 2012
Complement is crucial in the pathogenesis of ANCA-associated vasculitisCees G M Kallenberg, Peter HeeringaRheumatology (Oxford, England)|October 19, 2017
Towards precision medicine in ANCA-associated vasculitisKornelis S M van der Geest, Elisabeth Brouwer, Jan-Stephan Sanders, et al.APMIS. Supplementum|June 12, 2009
ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?Betty S van der Veen, Peter HeeringaMethods in Molecular Biology (Clifton, N.J.)|November 17, 2010
Bone marrow transplantations to study gene function in hematopoietic cellsMenno P J de Winther, Peter HeeringaKidney International|February 19, 2002
A protective role for endothelial nitric oxide synthase in glomerulonephritisPeter Heeringa, Eric Steenbergen, Harry van GoorCurrent Opinion in Rheumatology|December 20, 2012
Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal modelsFleur Schaper, Peter Heeringa, Marc Bijl, et al.Current Opinion in Rheumatology|December 16, 2003
Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal modelsDennis Huugen, Jan Willem Cohen Tervaert, Peter HeeringaNephrology (Carlton, Vic.)|April 2, 2009
Review article: Pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitisMirjan M Van Timmeren, Min Chen, Peter HeeringaPageof 22